Drugs@FDA document
SERTRALINE HYDROCHLORIDE Letter · NDA 215133 ORIG-2
Drugs@FDA document · ALMATICA · Oct 5, 2021
Key facts
| Drug name | SERTRALINE HYDROCHLORIDE |
|---|---|
| Document type | Letter |
| Application | NDA215133 |
| Submission | ORIG-2 |
| Company | ALMATICA |
| Document date | Oct 5, 2021 |
At a glance
- 10–99 Documents for this application
- None USP chapters cited in this application's documents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA documents
Drugs@FDA posts the letters, labels, reviews and other documents behind each drug application and supplement. Orca1 indexes every document's full text and flags complete response letters.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA application documents · Source date: